Optimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors

August 6, 2020

WEBINAR TITLE: Optimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors

LENGTH: 60 minutes

Overall description/goals of webinar: This webinar aims to review the cardiovascular outcomes trials of diabetes agents with a focus on heart failure risk reduction with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Presenters will offer a practical approach to optimizing pharmacotherapy using patient cases with diabetes and heart failure. In addition, presenters will offer strategies for overcoming barriers encountered with formulary decisions and patient care when considering SGLT-2 inhibitors.

INTRO/CME ANNOUNCEMENT: 5 minutes

 

PRESENTATION #1: _25__ minutes

LEARNING OBJECTIVES:

Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.

Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.

Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.

 

PRESENTATION #2: _25__ minutes

LEARNING OBJECTIVES:

Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.

Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.

Target Audience

Pharmacist

Learning Objectives

1. Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.

2. Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.

3. Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.

4. Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.

5. Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 1.00 Attendance
Course opens: 
06/08/2020
Course expires: 
09/07/2020
Event starts: 
08/06/2020 - 8:00am
Event ends: 
08/06/2020 - 5:00pm

WEBINAR TITLE: Optimizing Heart Failure & Diabetes Care: Finding Synergy with SGLT-2 Inhibitors

LENGTH: 60 minutes

Overall description/goals of webinar: This webinar aims to review the cardiovascular outcomes trials of diabetes agents with a focus on heart failure risk reduction with sodium-glucose cotransporter-2 (SGLT-2) inhibitors. Presenters will offer a practical approach to optimizing pharmacotherapy using patient cases with diabetes and heart failure. In addition, presenters will offer strategies for overcoming barriers encountered with formulary decisions and patient care when considering SGLT-2 inhibitors.

INTRO/CME ANNOUNCEMENT: 5 minutes

 

PRESENTATION #1: _25__ minutes

LEARNING OBJECTIVES:

Review evidence evaluating cardiovascular outcomes with SGLT-2 inhibitors.

Identify patients with heart failure for whom SGLT-2 inhibitor therapy should be considered.

Given a patient with heart failure and comorbid diabetes, develop a practical approach for optimizing heart failure pharmacotherapy using SGLT-2 inhibitors.

 

PRESENTATION #2: _25__ minutes

LEARNING OBJECTIVES:

Describe common barriers to prescribing SGLT-2 inhibitors in patients with heart failure and diabetes, including inpatient formulary considerations, shared responsibility of prescribing and monitoring, and patient access.

Given a patient with diabetes and comorbid heart failure, develop a practical approach for optimizing diabetes pharmacotherapy using SGLT-2 inhibitors.

Webinar
Pittsburgh, PA
United States

Ted Berei, Pharm.D., MBA, BCPS, BCCP

University of Wisconsin Hospitals and Clinics 

600 Highland Avenue | Madison, WI 53705 | F6/133-1530

Cell: 815-979-2260

TBerei@uwhealth.org

Twitter: @TedBerei

 

Heather P. Whitley, PharmD, BCPS, CDCES

Mahlon Turner Fellow in Outreach

Associate Clinical Professor

Department of Pharmacy Practice

Auburn University Harrison School of Pharmacy

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 1.00 Attendance
Please login or register to take this course.